Baker Bros. Advisors LP Harpoon Therapeutics, Inc. Transaction History

Baker Bros. Advisors LP

  • $9.86 Billion
  • Q2 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020
SELL
$11.11 - $24.72 $2.27 Million - $5.05 Million
-204,467 Closed
0 $0
Q1 2020

May 15, 2020
SELL
$10.74 - $16.32 $105,445 - $160,229
-9,818 Reduced 4.58%
204,467 $2.37 Million
Q1 2019

May 15, 2019
BUY
$9.47 - $17.01 $2.03 Million - $3.64 Million
214,285 New
214,285 $2.03 Million

Others Institutions Holding HARP

# of Institutions
2
Shares Held
353K
Call Options Held
0
Put Options Held
0
View Full List

About Harpoon Therapeutics, Inc.

HARP Quotes by TradingView
  • Ticker HARP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,106,800
  • Description
  • Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...
More about HARP
Track This Portfolio

Track Baker Bros. Advisors LP Portfolio

Follow Baker Bros. Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baker Bros. Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Baker Bros. Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email